Editas Medicine, Inc.

EDIT · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.3B · 87 employees
196
SEC Filings
$2.57
Close 2026-11-06
87
Employees

Business Summary

Editas Medicine is a gene editing company developing CRISPR-based genomic medicines. Its platform includes CRISPR/Cas9 and CRISPR/Cas12a technologies targeting more than 95% of the human genome. Lead program EDIT-401 is an in vivo therapy targeting LDL-C reduction via LDLR upregulation for hyperlipidemia. The company also partners with Bristol Myers Squibb and Immatics for CAR T and cancer cell therapies, and licenses Cas9 technology to Vertex Pharmaceuticals.

Latest Stock Quote

EDIT 2026-11-06 $2.57 O:$2.55 H:$2.63 L:$2.475 Vol:1.7M VWAP:$2.5505
origin leaf: null

Next Earnings

expected 2027-01-07

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001650664-26-000017EDGAR112K words
2025-03-052024-12-310001650664-25-000022EDGAR109K words
2024-02-282023-12-310001650664-24-000008EDGAR104K words
2023-02-222022-12-310001558370-23-001764EDGAR105K words
2022-02-242021-12-310001558370-22-001950EDGAR106K words
2021-02-262020-12-310001558370-21-001915EDGAR108K words
2020-02-262019-12-310001558370-20-001476EDGAR115K words
2019-03-012018-12-310001558370-19-001364EDGAR127K words
2018-03-082017-12-310001558370-18-001721EDGAR129K words
2017-03-032016-12-310001558370-17-001340EDGAR141K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-092026-09-300001650664-26-000103EDGAR24K words
2026-08-052026-06-300001650664-26-000083EDGAR23K words
2025-11-102025-09-300001650664-25-000156EDGAR21K words
2025-08-122025-06-300001650664-25-000125EDGAR21K words
2025-05-122025-03-310001650664-25-000073EDGAR19K words
2024-11-042024-09-300001650664-24-000121EDGAR16K words
2024-08-072024-06-300001650664-24-000097EDGAR15K words
2024-05-082024-03-310001650664-24-000037EDGAR13K words
2023-11-032023-09-300001650664-23-000017EDGAR17K words
2023-08-022023-06-300001558370-23-012936EDGAR17K words
2023-05-052023-03-310001558370-23-008308EDGAR14K words
2022-11-022022-09-300001558370-22-016012EDGAR19K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-090001650664-26-000100EDGAR2K words
2026-10-080001650664-26-000093EDGAR1K words
2026-08-050001650664-26-000082EDGAR2K words
2026-03-270001650664-26-000027EDGAR1K words
2026-03-090001650664-26-000013EDGAR2K words
2025-11-100001650664-25-000153EDGAR2K words
2025-10-090001650664-25-000148EDGAR1K words
2025-09-020001650664-25-000134EDGAR1K words
2025-08-120001650664-25-000123EDGAR2K words
2025-06-120001650664-25-000106EDGAR1K words

196 total filings indexed. 164 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

gene-editing-therapeutics in-vivo-genomic-medicines cardiovascular-disease-(hyperlipidemia) hematologic-diseases-(sickle-cell-disease,-beta-thalassemia) oncology-(car-t-cell-therapies) autoimmune-disease crispr/cas9 crispr/cas12a-(cpf1) non-homologous-end-joining-(nhej) homology-directed-repair-(hdr) lipid-nanoparticle-(lnp)-delivery protospacer-adjacent-motif-(pam)

Company Identity

CIK0001650664
TickerEDIT
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.editasmedicine.com
Listed2016-02-03

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: d25f90121dcdda83ffb113d0da97c61a29487ac49c9fa6a6b0e3e1f5262dcac4
parent: adb1ebe69cb8db5b23e5881b88e7bbd2f5d38a5e2305cca722402f4c33486609
content hash: 65a4c8fb1d04ecd4617d8cbd78b46b070667e97f207ab07e6a50141f18efd19f
signed: 2026-11-16T19:01:48.996Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up EDIT using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on EDIT, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/EDIT (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.